Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
05-Jul-2023 / 13:55 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Aubagne, July 5, 2023
Half-year liquidity contract statement for Sartorius Stedim Biotech
Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2023:
22,917 shares € 4,751,581.19 Number of executions on buy side on semester: 5,887 Number of executions on sell side on semester: 5,674 Traded volume on buy side on semester: 253,847 shares for € 72,788,724.35 Traded volume on sell side on semester: 242,831 shares for € 70,620,474.51
As a reminder the following resources appeared on the last half year statement on 31 December 2022 on the liquidity account:
11,901 shares € 6,895,585.95 Number of executions on buy side on semester: 4,259 Number of executions on sell side on semester: 4,361 Traded volume on buy side on semester: 166,507 shares for € 56,282,984.47 Traded volume on sell side on semester: 174,847 shares for € 59,810,740.92
The following resources appeared on the liquidity account when the activity started:
0 shares € 10,000,000.00
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a provider of innovative solutions, the company based in Aubagne, France, helps its customers to manufacture biotech medications safely, rapidly and economically. The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R sites as well as sales entities in Europe, North America and Asia. Sartorius Stedim Biotech delivers significant organic growth and regularly expands its portfolio through acquisitions of complementary technologies. In fiscal 2022, the company generated sales revenue of around 3.5 billion euros. At the end of 2022, around 12,000 employees were working for customers around the globe.
Contact
Petra Müller
Head of Investor Relations
+49 (0)551.308.6035
Petra.mueller2@sartorius.com
Sartorius Stedim Biotech S.A.
Z.I. Les Paluds
Avenue de Jouques, CS 91051
13781 Aubagne Cedex, France
Phone: +33.(0)4.42.84.56.00
Fax: +33.(0)4.42.84.56.19
www.sartorius.com
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
Total
5,887
253,847
72,788,724.35
5,674
242,831
70,620,474.51
02/01/2023
33
1,657
492,758.66
29
699
215,082.30
03/01/2023
40
1,700
504,033.00
31
1,500
446,505.00
04/01/2023
23
1,400
418,894.00
32
1,700
509,847.00
05/01/2023
32
1,800
542,988.00
29
1,300
393,796.00
06/01/2023
86
3,300
958,089.00
10
310
91,589.50
09/01/2023
13
700
202,601.00
22
1,200
349,500.00
10/01/2023
34
1,700
495,856.00
27
1,800
528,408.00
11/01/2023
19
749
222,752.60
87
3,201
974,256.36
12/01/2023
29
1,600
502,608.00
68
2,900
915,501.00
13/01/2023
21
1,200
380,304.00
40
1,500
477,600.00
16/01/2023
5
1,000
323,100.00
63
2,300
746,902.00
17/01/2023
77
2,411
767,710.62
30
1,224
391,300.56
18/01/2023
35
1,629
523,153.35
44
1,876
605,591.56
19/01/2023
76
2,400
755,208.00
16
700
221,508.00
20/01/2023
40
1,550
482,251.50
31
1,600
499,408.00
23/01/2023
30
1,267
395,798.13
37
1,500
471,015.00
24/01/2023
58
2,403
749,736.00
17
800
253,104.00
25/01/2023
39
1,600
487,696.00
22
1,400
427,798.00
26/01/2023
12
500
159,500.00
85
4,900
1,577,065.00
27/01/2023
47
2,307
744,907.23
50
2,100
680,757.00
30/01/2023
39
1,700
551,905.00
66
2,120
690,780.80
31/01/2023
53
3,093
992,048.82
32
1,600
514,800.00
01/02/2023
37
1,500
481,200.00
62
2,900
936,787.00
02/02/2023
-
-
-
70
3,100
1,047,180.00
03/02/2023
64
2,800
957,012.00
67
2,700
928,314.00
06/02/2023
49
2,400
838,176.00
43
2,200
771,100.00
07/02/2023
51
2,200
765,380.00
29
1,300
454,038.00
08/02/2023
42
2,100
737,310.00
47
1,500
532,305.00
09/02/2023
27
1,300
446,498.00
34
1,300
447,811.00
10/02/2023
40
1,800
611,604.00
37
1,600
546,048.00
13/02/2023
15
800
274,104.00
25
1,200
413,376.00
14/02/2023
66
3,000
1,039,230.00
49
2,100
734,328.00
15/02/2023
53
2,300
781,609.00
35
1,600
545,408.00
16/02/2023
58
2,300
774,502.00
27
1,200
407,868.00
17/02/2023
57
2,000
658,360.00
30
1,400
462,406.00
20/02/2023
29
1,202
396,912.42
30
1,700
563,856.00
21/02/2023
68
2,218
729,211.86
47
2,200
727,562.00
22/02/2023
67
2,980
975,085.80
26
1,300
428,948.00
23/02/2023
16
1,000
329,600.00
72
3,000
991,650.00
24/02/2023
69
3,400
1,113,636.00
39
2,200
724,746.00
27/02/2023
38
1,900
614,365.00
40
1,600
519,696.00
28/02/2023
112
3,200
1,009,216.00
15
711
225,834.93
01/03/2023
85
3,000
921,690.00
54
2,200
678,810.00
02/03/2023
65
2,200
673,596.00
76
3,200
984,320.00
03/03/2023
33
1,619
505,111.81
48
2,005
627,364.50
06/03/2023
46
1,845
574,348.50
58
2,495
778,814.25
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
Total
5,887
253,847
72,788,724.35
5,674
242,831
70,620,474.51
07/03/2023
62
2,400
753,696.00
59
2,702
854,021.14
08/03/2023
65
2,006
618,008.48
13
700
216,748.00
09/03/2023
42
1,600
487,344.00
77
2,600
797,810.00
10/03/2023
70
2,700
828,927.00
68
2,400
739,512.00
13/03/2023
113
4,001
1,212,182.97
87
4,300
1,308,146.00
14/03/2023
69
2,500
767,900.00
80
3,000
926,940.00
15/03/2023
63
3,000
902,490.00
1
1
308.50
16/03/2023
51
2,780
824,965.00
89
3,900
1,164,462.00
17/03/2023
59
2,900
881,252.00
63
2,800
854,700.00
20/03/2023
70
3,420
1,029,180.60
72
3,700
1,115,439.00
21/03/2023
49
1,800
546,300.00
88
3,513
1,071,254.22
22/03/2023
39
2,100
640,752.00
44
1,887
577,327.65
23/03/2023
58
2,900
874,756.00
45
2,124
642,212.64
24/03/2023
55
2,000
602,000.00
73
3,076
930,674.56
27/03/2023
33
1,500
458,445.00
114
3,199
981,101.31
28/03/2023
59
2,715
827,260.50
48
1,900
581,001.00
29/03/2023
47
1,737
522,715.41
60
2,700
815,454.00
30/03/2023
9
500
151,250.00
66
2,800
855,316.00
31/03/2023
161
6,000
1,751,520.00
-
-
-
03/04/2023
70
2,900
803,503.00
21
815
228,860.15
04/04/2023
79
2,800
762,300.00
60
2,320
633,824.00
05/04/2023
39
1,500
413,145.00
89
3,865
1,077,716.60
06/04/2023
77
2,600
744,588.00
76
2,767
794,461.04
11/04/2023
65
2,500
710,350.00
40
1,342
383,208.10
12/04/2023
69
2,567
714,190.74
88
4,089
1,148,477.43
13/04/2023
63
2,533
722,487.59
48
2,507
718,556.34
14/04/2023
27
1,500
434,055.00
44
1,946
566,538.98
17/04/2023
59
2,300
663,090.00
38
1,700
494,547.00
18/04/2023
69
2,600
738,738.00
71
2,300
655,845.00
19/04/2023
78
2,814
787,863.72
40
1,600
448,752.00
20/04/2023
70
4,386
1,140,710.88
17
633
165,099.06
21/04/2023
84
4,627
1,123,713.22
79
4,100
1,007,001.00
24/04/2023
34
1,500
386,595.00
67
3,067
793,892.95
25/04/2023
122
4,500
1,141,020.00
37
1,000
260,350.00
26/04/2023
80
3,400
809,982.00
54
2,600
622,206.00
27/04/2023
61
2,300
554,990.00
59
2,500
605,500.00
28/04/2023
45
2,178
527,163.12
54
2,145
520,806.00
02/05/2023
45
2,822
682,303.16
53
2,333
567,315.61
03/05/2023
20
1,105
269,752.60
63
2,322
570,677.94
04/05/2023
48
2,349
583,703.01
69
2,900
725,638.00
05/05/2023
21
1,145
290,784.20
44
1,400
356,748.00
08/05/2023
25
1,300
330,655.00
19
1,100
280,852.00
09/05/2023
62
2,506
625,898.56
20
900
226,800.00
10/05/2023
33
1,502
369,191.60
24
1,500
371,445.00
11/05/2023
51
2,000
491,100.00
35
1,401
346,593.39
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
Total
5,887
253,847
72,788,724.35
5,674
242,831
70,620,474.51
12/05/2023
34
1,400
342,748.00
48
1,699
417,529.25
15/05/2023
23
1,111
273,850.39
22
1,100
272,250.00
16/05/2023
64
2,353
572,579.02
41
1,882
459,226.82
17/05/2023
36
1,481
355,217.85
20
1,004
241,441.92
18/05/2023
5
300
72,621.00
30
1,196
291,010.72
19/05/2023
15
800
194,952.00
41
1,518
372,972.60
22/05/2023
41
1,800
434,952.00
33
1,800
437,904.00
23/05/2023
28
1,400
344,050.00
34
1,600
394,704.00
24/05/2023
47
2,100
512,673.00
53
2,012
492,255.92
25/05/2023
32
1,500
367,185.00
36
1,288
316,603.28
26/05/2023
23
1,400
338,716.00
36
1,700
413,899.00
29/05/2023
11
800
198,000.00
19
900
223,398.00
30/05/2023
34
1,600
397,856.00
54
1,900
473,898.00
31/05/2023
35
1,800
441,360.00
30
1,300
320,203.00
01/06/2023
-
-
-
38
1,400
350,406.00
02/06/2023
-
-
-
93
3,487
903,935.01
05/06/2023
33
1,107
291,384.54
34
1,230
324,806.10
06/06/2023
7
508
135,702.04
96
4,170
1,125,649.80
07/06/2023
68
3,192
860,595.12
69
2,866
775,367.64
08/06/2023
62
2,605
687,667.90
42
1,800
476,298.00
09/06/2023
44
1,995
529,173.75
40
1,800
479,286.00
12/06/2023
14
400
107,500.00
46
2,400
647,568.00
13/06/2023
30
1,580
431,703.40
36
1,926
530,092.98
14/06/2023
39
1,100
300,597.00
33
1,358
372,024.10
15/06/2023
49
2,000
542,760.00
52
2,300
627,141.00
16/06/2023
44
1,800
502,254.00
75
3,300
925,485.00
19/06/2023
70
3,500
827,015.00
-
-
-
20/06/2023
61
2,400
564,048.00
-
-
-
21/06/2023
53
2,400
561,264.00
-
-
-
22/06/2023
46
2,100
482,832.00
42
2,100
489,846.00
23/06/2023
47
2,452
580,241.28
22
1,000
238,050.00
26/06/2023
12
1,000
228,730.00
1
100
23,400.00
27/06/2023
77
4,100
892,160.00
-
-
-
28/06/2023
3
140
29,660.40
19
1,000
219,250.00
29/06/2023
-
-
-
19
700
156,947.00
30/06/2023
2
100
22,200.00
36
1,600
362,800.00
File: Half-year liquidity contract statement for Sartorius Stedim Biotech
Language: English Company: Sartorius Stedim Biotech SA Avenue de Jouques 13781 Aubagne France Phone: +33 44 284 5600 E-mail: sartorius.presse@sartorius.com Internet: www.sartorius-stedim.com ISIN: FR0013154002 Euronext Ticker: DIM AMF Category: Share buyback / Disposal of own shares / Information relating to the liquidity contract EQS News ID: 1673439 End of Announcement EQS News Service
1673439 05-Jul-2023 CET/CEST